HOME HELP SUBSCRIBE ARCHIVE SEARCH TABLE OF CONTENTS FEEDBACK EDITORIAL BOARD ABOUT DOC NEWS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Services Email this article to a friend Similar articles in this journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Goldfarb, B. Search for Related Content PubMed Articles by Goldfarb, B. Social Bookmarking                What's this?

People With Uncontrolled Diabetes Amenable to Inhaled Insulin

The availability of an inhalable form of insulin may increase the number of people with uncontrolled type 2 diabetes who are willing to start or intensify insulin therapy in order to achieve improved glycemic control, according to research presented at the annual meeting of the American Association of Clinical Endocrinologists, held April 11–15 in Seattle.

Richard M. Bergenstal, MD, executive director of the International Diabetes Center in Minneapolis, Minn., and colleagues conducted a survey of 609 people with type 2 diabetes who had glycated hemoglobin levels of 7.0 or more, 393 people taking two or more oral anti-diabetes agents, and 216 people taking one or more oral agents and insulin glargine.

Researchers found that when inhaled insulin was a therapeutic option, patients were significantly more likely to decide to include insulin in their future treatment regimen or choose a more intensive therapy. Nearly all participants expressed a preference for inhaled insulin when it was presented as an option.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

Services Email this article to a friend Similar articles in this journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Goldfarb, B. Search for Related Content PubMed Articles by Goldfarb, B. Social Bookmarking                What's this?